257 results on '"Fenwick, Craig"'
Search Results
52. Heterogenous Cellular and Humoral Immune Trajectories after SARS-CoV-2 Infection: Compensatory Responses in a Population-Based Cohort
53. Measurement of circulating CD21−CD27− B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.
54. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery
55. A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infection
56. HGF and CXCL13, Two Antagonizing Cytokines in Lung Inflammation and Fibrosis, Predict the Severity and the Mortality of COVID-19
57. Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
58. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
59. In Situ Characterization of Follicular Helper CD4 T Cells Using Multiplexed Imaging
60. Comparison of CyTOF assays across sites: Results of a six-center pilot study
61. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies
62. TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice
63. BCG Vaccination Induces Long-Term Functional Reprogramming of Human Neutrophils
64. Ocrelizumab Impairs the Phenotype and Function of Memory CD8 + T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
65. Stepwise anti-inflammatory and anti-SARS-CoV-2 effects following convalescent plasma therapy with full clinical recovery
66. Changes in SARS-CoV-2 Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies
67. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
68. T‐cell exhaustion in HIV infection
69. MOESM3 of Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
70. pH and driving force dependence of intramolecular oxyferryl heme reduction in myoglobin
71. Structural basis for broad HIV-1 neutralization by the MPER-specific human broadly neutralizing antibody LN01
72. A Subclass of Ras Proteins That Regulate the Degradation of IκB
73. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement
74. Tumor suppression of novel anti–PD-1 antibodies mediated through CD28 costimulatory pathway
75. Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody
76. CD32 + and PD-1 + Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
77. CD32+and PD-1+Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
78. Novel anti-PD-1 antibodies not acting through PD-1/pdl-1 blockade that enhance tumor clearance.
79. Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer
80. Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo
81. Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs
82. Identification of novel antagonistic anti-PD-1 antibodies that are non-blocking of the PD-1 / PD-L1 interaction.
83. Sensitive and frequent identification of high avidity neo-epitope specific CD8+T cells in immunotherapy-naive ovarian cancer.
84. Identification of BI-C, a Novel HIV-1 Non-Catalytic Site Integrase Inhibitor
85. Resistance Studies with HIV-1 Non-Catalytic Site Integrase Inhibitors Introduction
86. BI 224436, a Non-Catalytic Site Integrase Inhibitor, is a potent inhibitor of the replication of treatment-naïve and raltegravir-resistant clinical isolates of HIV-1, ICAAC conference
87. Emerging single-cell technologies in immunology
88. HIV VIRION PROFILING SUGGEST THAT CXCR3+CD4 T CELLS ARE THE MAIN HIV-PRODUCING CELLS.
89. CD40.SARS.CoV2 VACCINE, BUT NOT mRNA, INDUCES SPECIFIC CD8+ T MEMORY STEM CELLS.
90. Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
91. Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV
92. Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
93. Trapping and LC-MS identification of protein radicals formed in the horse heart metmyoglobin-H2O2 reaction
94. Rate of intramolecular reduction of oxyferryl iron in horse heart myoglobin
95. Training health professionals in the recognition, assessement and management of suicide risk
96. Comparison of CyTOF assays across sites: Results of a six-center pilot study
97. Local stabilities of horse cytochrome c metalloderivatives as probed by tryptic digestion and electrospray mass spectrometry
98. Trapping and LC−MS Identification of Protein Radicals Formed in the Horse Heart Metmyoglobin−H2O2 Reaction
99. Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion.
100. Maintenance Strategies for the Oil and Gas compared against the Food Industry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.